½ÃÀ庸°í¼­
»óǰÄÚµå
1791644

¼¼°èÀÇ ½ÉÀüµµ ºÎÇÏ °Ë»ç ½ÃÀå

ECG Stress Test

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Industry Analysts, Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 151 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ½ÉÀüµµ ºÎÇÏ °Ë»ç ½ÃÀåÀº 2030³â±îÁö 44¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 29¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ½ÉÀüµµ ºÎÇÏ °Ë»ç ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 6.9%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 44¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¿îµ¿ ºÎÇÏ °Ë»ç ½Ã½ºÅÛ Á¦Ç°Àº CAGR 5.2%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 18¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ºÆ®·¹½º ECG Á¦Ç° ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 8.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 7¾ï 6,640¸¸ ´Þ·¯, Áß±¹Àº CAGR 6.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ½ÉÀüµµ ºÎÇÏ °Ë»ç ½ÃÀåÀº 2024³â¿¡ 7¾ï 6,640¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 7¾ï 360¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 6.9%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 6.2%¿Í 6.1%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.8%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ½ÉÀüµµ ºÎÇÏ °Ë»ç ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

µðÁöÅÐÈ­µÇ´Â ½ÉÀå Áø´Ü¿¡¼­ ½ÉÀüµµ ºÎÇÏ °Ë»ç°¡ ¿©ÀüÈ÷ Áß¿äÇÑ ÀÌÀ¯´Â ¹«¾ùÀϱî?

½ÉÀå ¸ð´ÏÅ͸µÀÇ ±â¼ú ¹ßÀü¿¡µµ ºÒ±¸ÇÏ°í ½ÉÀüµµ ºÎÇÏ °Ë»ç´Â ÀÔÁõµÈ À¯¿ë¼º, Àú·ÅÇÑ °¡°Ý, ±¤¹üÀ§ÇÑ ÀÓ»óÀû Àû¿ë °¡´É¼ºÀ¸·Î ÀÎÇØ ¿©ÀüÈ÷ ½ÉÇ÷°ü Áø´ÜÀÇ ÇÙ½ÉÀ¸·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. Àü ¼¼°è ½ÉÀ庴 »ç¸ÁÀÚÀÇ 3ºÐÀÇ 1¿¡ À°¹ÚÇÏ´Â ½ÉÀ庴ÀÇ ºÎ´ãÀÌ °è¼Ó Áõ°¡ÇÔ¿¡ µû¶ó, ÀÇ·á ½Ã½ºÅÛÀº À§Çè¿¡ óÇÑ »ç¶÷µéÀ» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ´Â È¿À²ÀûÀ̰í Á¢±ÙÇϱ⠽¬¿î Áø´Ü µµ±¸¸¦ µµÀÔÇØ¾ß ÇÑ´Ù´Â ¾Ð¹ÚÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ½ÉÀüµµ ºÎÇÏ °Ë»ç´Â ÅëÁ¦µÈ ¿îµ¿ ½Ã ½ÉÀåÀÇ Àü±âÀû Ȱµ¿À» Æò°¡ÇÏ´Â °ÍÀ¸·Î ÇãÇ÷, ¹«Áõ»ó ½É±Ù°æ»ö, ºÎÁ¤¸Æ ¹× ÈÞ½Ä ½Ã¿¡´Â °¨ÁöµÇÁö ¾ÊÀ» ¼ö ÀÖ´Â ±âŸ ¿îµ¿ À¯¹ß¼º ½ÉÀå ÀÌ»óÀ» °¨ÁöÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. Á¤Àû ½ÉÀüµµ³ª ÷´Ü ¿µ»ó ±â¼ú°ú ´Þ¸® ½ÉÀüµµ ºÎÇÏ Å×½ºÆ®´Â »ý¸®Àû ºÎÇÏ ÇÏ¿¡¼­ ½ÉÀåÀÇ ¼º´ÉÀ» ½Ç½Ã°£À¸·Î ±â´ÉÀûÀ¸·Î Æò°¡ÇÏ¿© °ü»óµ¿¸Æ °ü·ù, ¸®µë ¾ÈÁ¤¼º, ¿îµ¿ ³»¼º¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. ECG ºÎÇÏ °Ë»ç´Â ÀÔ¿ø ¹× ¿Ü·¡ ȯÀÚ ¸ðµÎ¿¡¼­ ¼ö¼ú Àü Ŭ¸®¾î·±½º, ½ÉÀå ÀçȰÀÇ ÁøÇà »óȲ ÃßÀû ¹× ÁßÀç ÈÄ Æò°¡¿¡ ÀÏ»óÀûÀ¸·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÚ¿øÀÌ ÇÑÁ¤µÈ ȯ°æ¿¡¼­ CT ¾Þ±â¿À±×·¡Çdzª ÇÙÀÇÇÐ ¿µ»ó ÃÔ¿µÀÌ ºñ¿ëÀûÀ¸·Î ¾î·Á¿î °æ¿ì, ECG ºÎÇÏ Å×½ºÆ®´Â ½Ç¿ëÀûÀÎ ÃÖÀü¼± Áø´Ü ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ´Â ±âº»ÀûÀÎ ½ÉÀå Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä°¡ ºü¸£°Ô Áõ°¡Çϰí ÀÖ´Â ½ÅÈï ½ÃÀå¿¡¼­ ƯÈ÷ ±×·¸½À´Ï´Ù. ¶ÇÇÑ, ÀÏ¹Ý °³¾÷ÀÇ¿Í ¼øÈ¯±â Àü¹®ÀÇ ¸ðµÎ ÀÌ °Ë»ç¸¦ ¼±º° °Ë»ç µµ±¸·Î »ç¿ëÇÏ¿© ´õ ³ôÀº ¼öÁØÀÇ Áø´ÜÀÌ ÇÊ¿äÇÑÁö ¿©ºÎ¸¦ ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ´ç´¢º´, ºñ¸¸, °íÇ÷¾Ð°ú °°Àº ½ÉÇ÷°ü À§Çè ¿äÀÎÀÌ Àü ¼¼°èÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó, ECG ºÎÇÏ °Ë»ç´Â °øÁß º¸°Ç ¹× ¹Î°£ ÀÇ·á ü°è ¸ðµÎ¿¡¼­ È®Àå °¡´ÉÇϰí ÀÓ»óÀûÀ¸·Î ÀûÀýÇÑ µµ±¸·Î¼­ »õ·Î¿î ¼ö¿ä°¡ ¹ß»ýÇϰí ÀÖ½À´Ï´Ù.

±â¼úÀº ECG ºÎÇÏ Å×½ºÆ®ÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

Áö³­ 10³â°£ ½ÉÀüµµ ºÎÇÏ °Ë»ç´Â µðÁöÅÐ Çõ½ÅÀ» ÅëÇØ Á¤È®¼º, ȯÀÚ °æÇè, ±¤¹üÀ§ÇÑ ÀÓ»ó ¿öÅ©Ç÷οì¿ÍÀÇ ÅëÇÕÀÌ Å©°Ô °³¼±µÇ´Â µî ±â¼úÀûÀ¸·Î Å« º¯È­¸¦ °Þ¾ú½À´Ï´Ù. ÃֽŠºÎÇÏ Å×½ºÆ® ½Ã½ºÅÛ¿¡´Â °íÇØ»óµµ ECG ¼öÁý ¸ðµâÀÌ ³»ÀåµÇ¾î ÀÖ¾î °Ý·ÄÇÑ ¿òÁ÷ÀÓ Áß¿¡µµ º¸´Ù ¼±¸íÇϰí ÇØ¼®Çϱ⠽¬¿î ½ÅÈ£¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³¼±Àº ¾ÆÆ¼ÆÑÆ®¸¦ °¨¼Ò½Ã۰í, °ü»óµ¿¸Æ ±â´É ºÎÀü Áø´Ü¿¡ ÇʼöÀûÀÎ STºÐÀý ÀúÇÏ ¹× ºÎÁ¤¸Æ »ç°Ç°ú °°Àº ¹Ì¹¦ÇÑ º¯È­¸¦ °¨ÁöÇÒ ¼ö ÀÖ´Â ÀÓ»óÀÇÀÇ ´É·ÂÀ» Çâ»ó½Ãŵ´Ï´Ù. ¹«¼± ÅÚ·¹¸ÞÆ®¸®, ºí·çÅõ½º Áö¿ø Àü±Ø, ½Ç½Ã°£ ¿òÁ÷ÀÓ º¸Á¤ ¾Ë°í¸®ÁòÀ» ÅëÇØ ÀÌ °úÁ¤À» ´õ¿í °£¼ÒÈ­Çϰí ȯÀÚ¿¡°Ô Æí¾ÈÇÔÀ» ¼±»çÇÕ´Ï´Ù. ½º¸¶Æ® ¼ÒÇÁÆ®¿þ¾î Ç÷§ÆûÀº ÇöÀç ½Ç½Ã°£ ÇØ¼®À» Áö¿øÇϰí, ÀÚµ¿À¸·Î ÀÌ»ó ¡Èĸ¦ Ç¥½ÃÇϰí, ¿¹ºñ º¸°í¼­¸¦ ÀÛ¼ºÇÕ´Ï´Ù. ¶ÇÇÑ, EHR ¹× PACS ½Ã½ºÅÛ°úÀÇ ¿øÈ°ÇÑ ÅëÇÕÀ» ÅëÇØ ȯÀÚ µ¥ÀÌÅÍÀÇ Áï°¢ÀûÀÎ °øÀ¯ ¹× °Ë»öÀÌ °¡´ÉÇÏ¿© ½Å¼ÓÇÑ ÀÇ»ç°áÁ¤°ú ´ÙÇÐÁ¦°£ ÇùÀǸ¦ ÃËÁøÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº È¿À²¼ºÀÌ Áß¿ä½ÃµÇ´Â ¹Ù»Û ¼øÈ¯±â Ŭ¸®´Ð°ú Áø´Ü½ÇÇè½Ç¿¡¼­ ƯÈ÷ À¯¿ëÇÏ°Ô È°¿ëµÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »õ·Î¿î ·¯´×¸Ó½Å°ú ¿¡¸£°í¹ÌÅÍ ½Ã½ºÅÛÀº º¸´Ù ÀÎü°øÇÐÀûÀ̰í, ÇÁ·Î±×·¡¹ÖÀÌ °¡´ÉÇϸç, ´Ù¾çÇÑ ÇÇÆ®´Ï½º ¼öÁذú Áø´Ü ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü ÇÁ·ÎÅäÄÝÀ» ½ÇÇàÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸¹Àº ÀåºñµéÀº Áø´ÜÀÇ Á¤È®µµ¸¦ ³ôÀ̱â À§ÇØ ¿îµ¿ Áß ¶Ç´Â ¿îµ¿ Á÷ÈÄ¿¡ ½ÉÃÊÀ½ÆÄ, ÇÙÀÇÇÐ °ü·ù °Ë»ç µîÀÇ ¿µ»ó Áø´Ü ¹æ¹ýÀ» ÇÔ²² »ç¿ëÇÒ ¼ö ÀÖµµ·Ï µÇ¾î ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î, ÀÌ·¯ÇÑ ±â¼úÀû µµ¾àÀº ÀüÅëÀûÀÎ °Ë»ç¸¦ Çö´ëÈ­ÇÏ¿© 21¼¼±â µðÁöÅÐ ÇコÄÉ¾î ½Ã½ºÅÛ¿¡ ÀûÇÕÇÏ°Ô ¸¸µé°í, Áø´ÜÀÇ ½Å·Ú¼º°ú ¿öÅ©Ç÷οìÀÇ È¿À²¼ºÀ» Å©°Ô Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

ÀÓ»ó ÇÁ·ÎÅäÄݰú ȯÀÚ µ¿ÅÂÀÇ º¯È­°¡ ½ÃÀå ¿ªÇÐÀ» À籸¼ºÇϰí Àִ°¡?

ÀÓ»ó Áø·á °¡À̵å¶óÀÎÀÇ ¹ßÀü°ú ȯÀÚÃþÀÇ º¯È­´Â Àü ¼¼°è ECG ºÎÇÏ °Ë»ç ¼ö¿ä¿¡ ±ØÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÇ·á ±â°üÀº Á¶±â ¹ß°ßÀÌ Àå±âÀûÀÎ °á°ú¸¦ °³¼±Çϰí Àü¹ÝÀûÀÎ ÀÇ·á ºÎ´ãÀ» ÁÙÀÌ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ¿¹¹æÀû ½ÉÀå À§Çè °ü¸®·ÎÀÇ ÀüȯÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­ÀÇ ÀÏȯÀ¸·Î Áõ»óÀÌ Àִ ȯÀÚ»Ó¸¸ ¾Æ´Ï¶ó °¡Á··Â, °íÄÝ·¹½ºÅ×·Ñ, ÁÂ½Ä »ýȰ½À°ü µî À§ÇèÀÎÀÚ¸¦ °¡Áø ȯÀڵ鿡°Ô Àû±ØÀûÀÎ Áõ»óÀÌ ¾ø´õ¶óµµ ½ÉÀüµµ ºÎÇÏ °Ë»ç¸¦ ±ÇÇÏ´Â ÀÇ»çµéÀÌ ´Ã°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àû±ØÀûÀÎ ÀÚ¼¼·Î ÀÎÇØ ÀÏ»óÀûÀÎ °Ç°­°ËÁø, ÀÓ¿ø À£´Ï½º ÇÁ·Î±×·¥, Á÷Àå °Ç°­°ËÁøÀÇ ÀÏȯÀ¸·Î ½ºÆ®·¹½º °Ë»ç°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°è °í·ÉÈ­, ƯÈ÷ ÀϺ», µ¶ÀÏ, ¹Ì±¹ µî ¼±Áø±¹¿¡¼­´Â ³ëÈ­¿Í °ü·ÃµÈ ½ÉÀåÁúȯÀÇ À¯º´·ü·Î ÀÎÇØ ½ÉÇ÷°ü Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½ÉÀüµµ ºÎÇÏ °Ë»ç´Â ƯÈ÷ ¿¬·É¿¡ µû¸¥ ¿îµ¿ ÇÁ·ÎÅäÄÝ ¹× ¾à¸®ÇÐÀû ¿É¼Ç°ú °áÇÕÇÏ¿© ÀÌ °èÃþ¿¡°Ô ¾ÈÀüÇÏ°í ºñħ½ÀÀûÀÎ ´ë¾ÈÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ƯÈ÷ ½ºÆ÷Ã÷ ÀÇÇп¡¼­´Â ¿îµ¿¼±¼öµéÀÌ Á¤±âÀûÀ¸·Î ½ÉÀüµµ ºÎÇÏ °Ë»ç¸¦ ÅëÇØ ¿îµ¿ ´É·ÂÀÇ ±âÁؼ±À» Æò°¡ÇÏ°í ±Ùº»ÀûÀÎ ½ÉÀå À§ÇèÀ» È®ÀÎÇϱâ À§ÇØ Á¤±âÀûÀ¸·Î ½ÉÀüµµ ºÎÇÏ °Ë»ç¸¦ ¹Þ½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚµéÀÇ ±â´ëÄ¡°¡ ÁøÈ­Çϸ鼭 ÀÏ»ó »ýȰ¿¡ ÁöÀåÀ» ÃÖ¼ÒÈ­Çϸ鼭 º¸´Ù ºü¸£°í Æí¸®ÇÑ Áø´ÜÀ» ¿øÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú, ¸ð¹ÙÀÏ ½ÉÀüµµ ½ºÆ®·¹½º °Ë»ç ÀåÄ¡ ¹× ¿Ü·¡ ±â¹Ý Áø´Ü ¼­ºñ½ºÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. º¸Çè»çµéµµ °Ë»çÀÇ ¿¹¹æÀû °¡Ä¡¸¦ ÀνÄÇÏ°í ¿¬ 1ȸ °ËÁø ¹× º¸Çè °è¾à Àü Æò°¡¿¡ ´ëÇÑ È¯±ÞÀ» Á¦°øÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¼ö¿ä¸¦ ´õ¿í ÀÚ±ØÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼¸¦ Á¾ÇÕÇØ º¸¸é, ´Ù¾çÇÑ ¿¬·É´ë, À§Çè ÇÁ·ÎÆÄÀÏ, Áø·á ȯ°æ¿¡¼­ ECG ½ºÆ®·¹½º °Ë»ç°¡ º¸´Ù ±¤¹üÀ§ÇÏ°í ´Ù¾çÇÏ°Ô »ç¿ëµÇ´Â ¹æÇâÀ¸·Î ÀüȯµÇ°í ÀÖÀ½À» ¾Ë ¼ö ÀÖ½À´Ï´Ù.

½ÉÀüµµ ºÎÇÏ Å×½ºÆ® ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀå ¿äÀÎÀº ¹«¾ùÀΰ¡?

½ÉÀüµµ ºÎÇÏ Å×½ºÆ® ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü, ÀÓ»ó ¿ä±¸ »çÇ×ÀÇ º¯È­, ÀÇ·á ¼­ºñ½º Á¦°ø ¸ðµ¨ÀÇ ÁøÈ­, ±¤¹üÀ§ÇÑ Àα¸ Åë°èÇÐÀû º¯È­¿¡ »Ñ¸®¸¦ µÐ ¿©·¯ °¡Áö ¿¬µ¿µÈ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁý´Ï´Ù. ±â¼úÀûÀ¸·Î´Â AI¸¦ Ȱ¿ëÇÑ ºÐ¼®, µ¥ÀÌÅÍ Á¤È®µµ Çâ»ó, ¹«¼± ½Ã½ºÅÛ, EHR ÅëÇÕ µî ½ºÆ®·¹½º Å×½ºÆ® ±â±âÀÇ Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀ¸·Î º´¿ø, ¼øÈ¯±â³»°ú Áø·á¼Ò, Áø´Ü¼¾ÅÍ¿¡¼­ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÃֽŠ½Ã½ºÅÛÀº Áø´Ü ¿À·ù¸¦ ÁÙÀ̰í 󸮷®À» Çâ»ó½ÃÄÑ ´ë·®ÀÇ °Ë»ç°¡ ÇÊ¿äÇÑ È¯°æ¿¡ ÀûÇÕÇÕ´Ï´Ù. ÀÓ»óÀû °üÁ¡¿¡¼­ Çù½ÉÁõ, ½ÉºÎÀü, ºÎÁ¤¸Æ°ú °°Àº ½ÉÇ÷°ü ÁúȯÀÇ ¼¼°èÀû ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÉÀüµµ ºÎÇÏ °Ë»ç¿Í °°Àº ½Å¼ÓÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ºñħ½ÀÀû Æò°¡ µµ±¸ÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °æÁ¦ ¼ºÀåÀ¸·Î ÀÎÇØ ÀÇ·á Á¢±Ù¼ºÀÌ °³¼±µÇ°í ÀÖ´Â °¡¿îµ¥, ºñ¿ë È¿À²ÀûÀÎ Áø´ÜÀÌ ÇʼöÀûÀÎ °³¹ßµµ»ó±¹À» Áß½ÉÀ¸·Î ȯÀÚ ¼ö°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½ÉÀüµµ ºÎÇÏ °Ë»ç´Â ½ÉÀå °Ç°­ »óÅ¿¡ ´ëÇÑ Áß¿äÇÑ ÅëÂû·ÂÀ» Á¦°øÇϸ鼭µµ ¿µ»ó Áø´ÜÀ» ¸¹ÀÌ »ç¿ëÇÏ´Â ¹æ¹ýÀ» ´ëüÇÒ ¼ö ÀÖ´Â Àúºñ¿ë Áø´Ü ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÀÇ·á º¸Çè Á¦°ø¾÷ü´Â ƯÈ÷ Á¶±â °³ÀÔÀÌ Àå·ÁµÇ´Â °¡Ä¡ ±â¹Ý ÀÇ·á ȯ°æ¿¡¼­ ºÎÇÏ ½ÉÀüµµ¸¦ Æ÷ÇÔÇÑ ½ÉÀå °ËÁø¿¡ ´ëÇÑ »óȯ ±âÁØÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. ¿Ü·¡ Áø´Ü Ŭ¸®´Ð, ¿Ü·¡ ½ÉÀå Áø·á ¼­ºñ½º, À£ºù Á᫐ °Ç°­ ¸ðµ¨ÀÇ È®»êÀ¸·Î ECG ½ºÆ®·¹½º °Ë»çÀÇ °¡¿ë¼º°ú ÀÎÁöµµ°¡ ´Ù¾çÇÑ ¼ÒºñÀÚÃþ¿¡¼­ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½ºÆ÷Ã÷ ÆÀ, ±â¾÷ À£´Ï½º ÇÁ·Î±×·¥, ÀÓ¿ø °Ç°­ ÆÐŰÁö¿¡¼­ Ç¥ÁØ °Ç°­ Æò°¡ÀÇ ÀϺηΠECG ½ºÆ®·¹½º Æò°¡¸¦ Æ÷ÇÔÇÏ´Â °æ¿ì°¡ ´Ã°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ´Ù¾çÇÑ ÃÖÁ¾ »ç¿ë ÃËÁø¿äÀÎÀº ¿ìÈ£ÀûÀÎ ±ÔÁ¦ ȯ°æ°ú °­·ÂÇÑ ÀÓ»óÀû Ÿ´ç¼º È®Àΰú ÇÔ²² ½ÉÀüµµ ºÎÇÏ Å×½ºÆ® ½ÃÀåÀ» Áö¼ÓÀûÀ¸·Î ¹ßÀü½ÃÄÑ ±âÁ¸ ¹× ½ÅÈï ½ÉÇ÷°ü Ä¡·á ¸ðµ¨ ¸ðµÎ¿¡¼­ °ü·Ã¼ºÀ» º¸ÀåÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(¿îµ¿ ºÎÇÏ °Ë»ç ½Ã½ºÅÛ Á¦Ç°, ºÎÇÏ ½ÉÀüµµ Á¦Ç°, ºÎÇÏ Ç÷¾Ð ¸ð´ÏÅÍ Á¦Ç°, ÆÞ½º¿Á½Ã¹ÌÅÍ Á¦Ç°), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø ÃÖÁ¾»ç¿ëÀÚ, Áø´Ü¼¾ÅÍ ÃÖÁ¾»ç¿ëÀÚ, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ÃÖÁ¾»ç¿ëÀÚ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

  • ASPEL S.A.
  • BTL Industries
  • Cardioline S.p.A.
  • Contec Medical Systems Co., Ltd.
  • Cosmed Srl
  • Custo med GmbH
  • GE HealthCare
  • Henry Schein Medical
  • Hillrom(now part of Baxter International Inc.)
  • Labtech Ltd.
  • Medical Device Depot, Inc.
  • MGC Diagnostics Corporation
  • Mortara Instrument, Inc.(now part of Baxter International Inc.)
  • Nasan Medical Electronics Pvt. Ltd.
  • Norav Medical Ltd.
  • Philips Healthcare
  • Recorders & Medicare Systems Pvt Ltd(RMS)
  • Schiller AG
  • SunTech Medical, Inc.
  • Welch Allyn(now part of Baxter International Inc.)

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä
  • ÁÖ¿ä ±â¾÷
  • ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
  • ¼¼°è ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ºÐ¼®

  • ¹Ì±¹
  • ij³ª´Ù
  • ÀϺ»
  • Áß±¹
  • À¯·´
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ¿µ±¹
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ Áö¿ª

Á¦4Àå °æÀï

LSH 25.08.21

Global ECG Stress Test Market to Reach US$4.4 Billion by 2030

The global market for ECG Stress Test estimated at US$2.9 Billion in the year 2024, is expected to reach US$4.4 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Exercise Testing Systems Product, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Stress ECG Product segment is estimated at 8.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$766.4 Million While China is Forecast to Grow at 6.9% CAGR

The ECG Stress Test market in the U.S. is estimated at US$766.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$703.6 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.2% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global ECG Stress Test Market - Key Trends & Drivers Summarized

Why Is ECG Stress Testing Still Crucial in a Digitally Advancing Cardiac Diagnostics Landscape?

Despite significant technological evolution in cardiac monitoring, the ECG stress test remains a cornerstone of cardiovascular diagnostics due to its proven utility, affordability, and broad clinical applicability. As the global burden of heart disease continues to grow-now accounting for nearly one-third of all global deaths-healthcare systems are under increasing pressure to implement efficient, accessible diagnostic tools that can identify at-risk individuals early. ECG stress testing, which evaluates the heart’s electrical activity during controlled physical exertion, remains indispensable for detecting ischemia, silent myocardial infarctions, arrhythmias, and other exertion-induced cardiac abnormalities that may go undetected at rest. Unlike static ECG or advanced imaging technologies, ECG stress testing is a real-time functional assessment of cardiac performance under physiological load, providing insights into coronary perfusion, rhythm stability, and exercise tolerance. It is routinely used for pre-operative clearance, cardiac rehab progress tracking, and post-intervention assessments in both inpatient and outpatient settings. In resource-limited settings, where CT angiography or nuclear imaging is cost-prohibitive, ECG stress tests offer a practical, frontline diagnostic method. This is especially true in emerging markets where demand for basic cardiac diagnostics is rapidly growing. Additionally, general practitioners and cardiologists alike rely on this test as a triaging tool, helping determine the need for more advanced diagnostics. As cardiovascular risk factors such as diabetes, obesity, and hypertension rise globally, ECG stress testing is experiencing renewed demand as a scalable and clinically relevant tool within both public health and private healthcare frameworks.

How Is Technology Enhancing the Accuracy and Efficiency of ECG Stress Testing?

The ECG stress test has undergone a major technological transformation over the past decade, with digital innovation vastly improving its precision, patient experience, and integration with broader clinical workflows. Modern stress test systems incorporate high-resolution ECG acquisition modules that provide clearer and more interpretable signals, even during periods of intense motion. This improvement reduces artifacts and enhances the clinician’s ability to detect subtle changes such as ST-segment depression or arrhythmic events that are critical for diagnosing coronary insufficiency. Wireless telemetry, Bluetooth-enabled electrodes, and real-time motion correction algorithms have also made the process more streamlined and comfortable for patients. Smart software platforms now assist with real-time interpretation, automatically flagging abnormalities and generating preliminary reports-thus reducing dependence on manual interpretation and lowering the risk of human error. Furthermore, seamless integration with EHRs and PACS systems allows for instant sharing and retrieval of patient data, facilitating quicker decision-making and interdisciplinary consultations. These advancements are particularly beneficial in busy cardiology practices and diagnostic labs where efficiency is crucial. In addition, newer treadmill and ergometer systems are more ergonomic, programmable, and capable of executing custom protocols for different fitness levels and diagnostic needs. Many devices now support combined imaging modalities, such as echocardiography or nuclear perfusion studies, during or immediately after exercise to enhance diagnostic accuracy. Overall, these technological leaps have modernized a traditional test, making it compatible with 21st-century digital healthcare systems while significantly improving its diagnostic reliability and workflow efficiency.

Are Changing Clinical Protocols and Patient Demographics Reshaping Market Dynamics?

The evolution of clinical practice guidelines and changing patient demographics are dramatically influencing the global demand for ECG stress tests. Medical institutions are increasingly shifting toward proactive cardiac risk management, wherein early detection plays a critical role in improving long-term outcomes and reducing the overall healthcare burden. As part of this shift, more physicians are recommending ECG stress tests not only for symptomatic patients but also for those with risk factors such as family history, high cholesterol, and sedentary lifestyles-even in the absence of active symptoms. This proactive stance has led to an increase in stress testing as part of routine health screenings, executive wellness programs, and workplace health checks. Moreover, the aging population worldwide-particularly in developed nations such as Japan, Germany, and the United States-is generating higher demand for cardiovascular diagnostics, given the prevalence of age-related cardiac conditions. ECG stress tests offer a safe, non-invasive option for this demographic, especially when paired with age-appropriate exercise protocols or pharmacological alternatives. Younger populations are also showing interest, particularly in sports medicine, where athletes undergo routine ECG stress tests to assess performance baselines and identify any underlying cardiac risks. Additionally, patient expectations are evolving-individuals now seek faster, more convenient diagnostics with minimal disruption to daily routines. As a result, there is growing adoption of mobile ECG stress testing units and outpatient-based diagnostic services. Insurance companies are also recognizing the test’s preventive value, offering reimbursement for annual screenings or pre-policy assessments, which further stimulates demand. Together, these trends indicate a clear shift toward more widespread and diverse use of ECG stress testing across different age groups, risk profiles, and care settings.

What Is Fueling the Continued Growth of the ECG Stress Test Market?

The growth in the ECG stress test market is driven by several interlinked factors rooted in technological advancement, changing clinical requirements, evolving healthcare delivery models, and broader demographic shifts. On the technology front, continuous innovation in stress test equipment-including AI-enhanced analysis, improved data accuracy, wireless systems, and EHR integration-has increased adoption among hospitals, cardiology practices, and diagnostic centers. These modern systems reduce diagnostic errors and improve throughput, making them ideal for high-volume environments. From a clinical perspective, the increasing global burden of cardiovascular conditions such as angina, heart failure, and arrhythmias is driving the need for quick, reliable, and non-invasive assessment tools like the ECG stress test. Patient populations are also expanding, particularly in developing regions where economic growth is improving access to healthcare, but where cost-effective diagnostics remain essential. The ECG stress test offers a lower-cost alternative to imaging-heavy modalities while still delivering critical insights into cardiac health. Additionally, health insurance providers are broadening reimbursement criteria for cardiac screening, including stress ECGs, particularly in value-based care environments where early intervention is encouraged. The proliferation of outpatient diagnostic clinics, ambulatory cardiac care services, and wellness-focused health models is increasing the availability and visibility of ECG stress testing to broader consumer segments. Sports teams, corporate wellness programs, and executive health packages are increasingly including ECG stress assessments as part of standard health evaluations. These diverse end-use drivers, combined with supportive regulatory environments and strong clinical validation, continue to power the ECG stress test market forward, ensuring its relevance in both traditional and emerging models of cardiovascular care.

SCOPE OF STUDY:

The report analyzes the ECG Stress Test market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product, Pulse Oximeters Product); End-User (Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 47 Featured) -

  • ASPEL S.A.
  • BTL Industries
  • Cardioline S.p.A.
  • Contec Medical Systems Co., Ltd.
  • Cosmed Srl
  • Custo med GmbH
  • GE HealthCare
  • Henry Schein Medical
  • Hillrom (now part of Baxter International Inc.)
  • Labtech Ltd.
  • Medical Device Depot, Inc.
  • MGC Diagnostics Corporation
  • Mortara Instrument, Inc. (now part of Baxter International Inc.)
  • Nasan Medical Electronics Pvt. Ltd.
  • Norav Medical Ltd.
  • Philips Healthcare
  • Recorders & Medicare Systems Pvt Ltd (RMS)
  • Schiller AG
  • SunTech Medical, Inc.
  • Welch Allyn (now part of Baxter International Inc.)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • ECG Stress Test - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Coronary Artery Disease Throws the Spotlight on Early Diagnostic Tools Like ECG Stress Testing
    • Growing Demand for Non-Invasive and Cost-Effective Cardiac Evaluation Drives Adoption Across Healthcare Settings
    • Aging Global Population and Increased Cardiovascular Risk Expand Addressable Market for Stress ECG Devices
    • Technological Advancements in Treadmill and Ergometer Integration Strengthen the Business Case for Modernized Stress Testing Systems
    • Wider Use in Pre-Operative Risk Assessment and Routine Health Checkups Propels Market Growth
    • Integration with Electronic Health Records (EHRs) and Digital Platforms Enhances Workflow and Diagnostic Accuracy
    • Expansion of Cardiac Rehab and Preventive Cardiology Services Generates Demand for Exercise ECG Monitoring
    • Increased Awareness Among Primary Care Providers Fuels Referrals for Early Cardiac Function Screening
    • Portable and Wireless ECG Stress Testing Solutions Drive Adoption in Ambulatory and Rural Care Environments
    • Growing Role in Sports Medicine and Occupational Health Assessment Creates New Market Avenues
    • Healthcare Cost Containment Efforts Spur Preference for Exercise ECG Over Advanced Imaging in Initial Screening
    • Rising Utilization in Emerging Markets Due to Infrastructure Development and Public Health Initiatives
    • Integration of AI and Decision-Support Tools in ECG Interpretation Accelerates Diagnostic Efficiency
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World ECG Stress Test Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for ECG Stress Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for ECG Stress Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Exercise Testing Systems Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Exercise Testing Systems Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Stress ECG Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Stress ECG Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Stress Blood Pressure Monitors Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Stress Blood Pressure Monitors Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Pulse Oximeters Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Pulse Oximeters Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Diagnostic Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Ambulatory Surgery Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • ECG Stress Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for ECG Stress Test by Product - Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for ECG Stress Test by Product - Percentage Breakdown of Value Sales for Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for ECG Stress Test by End-user - Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for ECG Stress Test by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2025 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for ECG Stress Test by Product - Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for ECG Stress Test by Product - Percentage Breakdown of Value Sales for Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for ECG Stress Test by End-user - Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for ECG Stress Test by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2025 & 2030
  • JAPAN
    • ECG Stress Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for ECG Stress Test by Product - Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for ECG Stress Test by Product - Percentage Breakdown of Value Sales for Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product for the Years 2025 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for ECG Stress Test by End-user - Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for ECG Stress Test by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2025 & 2030
  • CHINA
    • ECG Stress Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for ECG Stress Test by Product - Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China 6-Year Perspective for ECG Stress Test by Product - Percentage Breakdown of Value Sales for Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product for the Years 2025 & 2030
    • TABLE 34: China Recent Past, Current & Future Analysis for ECG Stress Test by End-user - Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: China 6-Year Perspective for ECG Stress Test by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2025 & 2030
  • EUROPE
    • ECG Stress Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 36: Europe Recent Past, Current & Future Analysis for ECG Stress Test by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 37: Europe 6-Year Perspective for ECG Stress Test by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for ECG Stress Test by Product - Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe 6-Year Perspective for ECG Stress Test by Product - Percentage Breakdown of Value Sales for Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product for the Years 2025 & 2030
    • TABLE 40: Europe Recent Past, Current & Future Analysis for ECG Stress Test by End-user - Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Europe 6-Year Perspective for ECG Stress Test by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2025 & 2030
  • FRANCE
    • ECG Stress Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 42: France Recent Past, Current & Future Analysis for ECG Stress Test by Product - Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: France 6-Year Perspective for ECG Stress Test by Product - Percentage Breakdown of Value Sales for Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product for the Years 2025 & 2030
    • TABLE 44: France Recent Past, Current & Future Analysis for ECG Stress Test by End-user - Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: France 6-Year Perspective for ECG Stress Test by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2025 & 2030
  • GERMANY
    • ECG Stress Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 46: Germany Recent Past, Current & Future Analysis for ECG Stress Test by Product - Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Germany 6-Year Perspective for ECG Stress Test by Product - Percentage Breakdown of Value Sales for Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product for the Years 2025 & 2030
    • TABLE 48: Germany Recent Past, Current & Future Analysis for ECG Stress Test by End-user - Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Germany 6-Year Perspective for ECG Stress Test by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2025 & 2030
  • ITALY
    • TABLE 50: Italy Recent Past, Current & Future Analysis for ECG Stress Test by Product - Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Italy 6-Year Perspective for ECG Stress Test by Product - Percentage Breakdown of Value Sales for Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product for the Years 2025 & 2030
    • TABLE 52: Italy Recent Past, Current & Future Analysis for ECG Stress Test by End-user - Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Italy 6-Year Perspective for ECG Stress Test by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2025 & 2030
  • UNITED KINGDOM
    • ECG Stress Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 54: UK Recent Past, Current & Future Analysis for ECG Stress Test by Product - Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: UK 6-Year Perspective for ECG Stress Test by Product - Percentage Breakdown of Value Sales for Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product for the Years 2025 & 2030
    • TABLE 56: UK Recent Past, Current & Future Analysis for ECG Stress Test by End-user - Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: UK 6-Year Perspective for ECG Stress Test by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for ECG Stress Test by Product - Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 6-Year Perspective for ECG Stress Test by Product - Percentage Breakdown of Value Sales for Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product for the Years 2025 & 2030
    • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for ECG Stress Test by End-user - Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Rest of Europe 6-Year Perspective for ECG Stress Test by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2025 & 2030
  • ASIA-PACIFIC
    • ECG Stress Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for ECG Stress Test by Product - Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 6-Year Perspective for ECG Stress Test by Product - Percentage Breakdown of Value Sales for Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product for the Years 2025 & 2030
    • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for ECG Stress Test by End-user - Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Asia-Pacific 6-Year Perspective for ECG Stress Test by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for ECG Stress Test by Product - Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Rest of World 6-Year Perspective for ECG Stress Test by Product - Percentage Breakdown of Value Sales for Exercise Testing Systems Product, Stress ECG Product, Stress Blood Pressure Monitors Product and Pulse Oximeters Product for the Years 2025 & 2030
    • TABLE 68: Rest of World Recent Past, Current & Future Analysis for ECG Stress Test by End-user - Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of World 6-Year Perspective for ECG Stress Test by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User, Ambulatory Surgery Centers End-User and Other End-Users for the Years 2025 & 2030

IV. COMPETITION

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦